3 more popular blue chip ASX shares I'm avoiding

I'm in no rush to buy BHP Billiton Limited (ASX:BHP) shares, Commonwealth Bank of Australia (ASX:CBA) shares and Coca-Cola Amatil Ltd (ASX:CCL) shares.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

I'm in no rush to buy BHP Billiton Limited (ASX: BHP) shares, Commonwealth Bank of Australia (ASX: CBA) shares and Coca-Cola Amatil Ltd (ASX: CCL) shares.

"Nobody goes there anymore. It's too crowded" – Yogi Berra

This article follows another piece I wrote on three blue chip ASX shares to avoid. In that article I explained why avoiding shares altogether is one of the greatest advantages to individual investors.

Basically, it boils down to the idea that we don't need to buy or sell all 2,000 shares on the market because we make money by holding shares – not buying or selling. 

Academics have shown that if an investor knows what he or she is doing and builds a portfolio of 15-20 shares they will outperform investors who hold more shares.

The finding relates to two concepts:

  • Backing your best investment ideas (aka 'conviction'), and
  • Downside protection (read: diversification)

On the second point, academics have further shown that 10 stocks can reduce the diversifiable risk of a portfolio by as much as 70%, while 30 stocks is as good as it gets for random stock pickers.

A couple tips and tricks

To make the process of identifying good ASX businesses easier, I'm filtering out all of the industries and businesses that I believe are not worth my time. For example, I choose not to invest in mining companies.

Therefore, despite its size, BHP Billiton is a company I'm avoiding. That doesn't mean 'buy' or 'sell', just avoid. As I have repeatedly said, I have no ability to forecast commodity prices better than anyone else.

I won't invest in companies if I don't understand how they plan to make money in the future and prefer companies that can set the prices of their products and/or services. 

After the filtering process, it's time to consider valuation. That's where these next two ASX companies fall down.

Coca-Cola Amatil is Australia's, and some neighbouring countries', bottler and distributor of Coca-Cola products. They also sell Beam alcohol beverages. I held shares of the company in the past (they were dark days) because I had hoped they would revive their brand's potential.

However, in the past five years, Coca-Cola's profits per share have fallen – each year.

Profits or earnings per share (EPS) is the best way to measure the profitability of a business.

Pro tip: If a company is NOT growing its EPS, the only way you make money is by sentiment changing.

What that means is, if you buy a company with a price-earnings ratio (P/E) of 10x and you plan to make money from it, the person you sell your shares to must buy the shares at a higher P/E ratio (e.g. 15x). The only way that can happen is if sentiment changes — because the EPS won't!

Of course, I'm talking about capital growth — you can still receive a dividend.

Unfortunately, I am not willing to bet the sentiment around Amatil's fizzy drinks and alcohol changes anytime soon.

Coca-Cola Amatil shares trade on a P/E of 24x — the market average is 18x.

This brings me to Commonwealth Bank of Australia.

Australia's largest company has done an exceptional job of growing its profits over the past two decades. However, its EPS growth has slowed dramatically over recent years. EPS is up 5% in two years.

Let's not forget that Australia's banking system has experienced booming house prices, plunging bad debt charges and non-stop economic growth.

Looking ahead, however, the outlook is not so rosy.

While the dividend should reward patient shareholders, I do not believe the profits will.

So, with over 2,000 companies on the ASX, why would I buy a company that I do not believe will grow its profits?

Motley Fool Contributor Owen Raszkiewicz does not have a financial interest in any company mentioned. Owen welcomes and encourages your feedback. You can follow him on Twitter @OwenRask. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »